BlackRock

BlackRock

BLK

$ 1,047.78

$18.19 1.77% 74%

IBD Stock Analysis

• Four weeks tight has 1068.34 entry, but is actionable on bounce from 21-day line

Composite Rating

89/99

Industry Group Ranking

54/197

Emerging Pattern

Three Weeks Tight

Three Weeks Tight

After a breakout a stock will sometimes consolidate tightly. A three-weeks tight is when a stock closes within 1% to 1.5% of the prior week's close. A four-weeks-tight pattern also is possible Offers entry for existing holders to add shares.

* Not real-time data. All data shown was captured at 12:59PM EST on 12/05/2024.

BlackRock (BLK) is the IBD Stock Of The Day as it bets big on Wall Street's hottest market and flourishes the most successful bitcoin ETF. BlackRock stock offered an early entry on Thursday.

On Monday, BlackRock said it has agreed to buy private-credit manager HPS Investment Partners in a $12 billion all-stock deal. The world's largest asset manager continued its push into private-credit markets, which the Wall Street Journal called one of Wall Street's hottest markets right now. Its third big acquisition of the year builds on efforts to keep more client business in-house and generate higher fees.

And as the bitcoin price crossed $100,000, BlackRock savored a milestone of its own. BlackRock's iShares Bitcoin ETF (IBIT) surpassed $50 billion in assets on Thursday.

BlackRock Stock Bounces, Financial Stocks Acting Well

Shares of BlackRock broke a slight downtrend in a four-weeks-tight pattern on the stock market today. BlackRock stock bounced from its 21-day exponential moving average, extending its bounce from near the 10-week line and offering an early entry.

The financial stock continues to work on a 1,068.34 traditional buy point, according to MarketSurge pattern recognition Shares traded about 2% below the entry on Thursday.

The relative strength line for BLK stock is not far from mid-November highs. If the RS line moves to new highs as the investment giant tries to break out, it would send a positive signal. A rising RS line means that a stock is outperforming the S&P 500 index. It is the blue line in the chart provided.

Financial and bank stocks broadly led the stock market's November rally. Investors bet that incoming President Donald Trump's administration will loosen regulations, which should especially help this heavily regulated sector.

A number of financial stocks can be found on top IBD lists for stocks to buy and research.

Blue Owl Capital (OWL) and Tradeweb Markets (TW) are on the IBD Leaderboard. App-based insurance upstarts Lemonade (LMND) and Root (ROOT) are on the IBD 50 list of top growth stocks. So are Toast (TOST) and Robinhood Markets (HOOD). Gallagher (AJG) and Kinsale Capital (KNSL) are on the Long-Term Leaders list.

BlackRock Earnings Acceleration

The IBD Stock Checkup tool shows that BlackRock stock earns a solid Composite Rating of 89 out of 99. The rating rolls various fundamental and technical metrics into one easy-to-use score.

Additionally, BlackRock shows an RS Rating of 82 and EPS Rating of 76, also out of a best-possible 99.

In the third quarter, BlackRock earnings trudged up 5% as revenue rose 15%. But for the full year, analysts project that BlackRock earnings per share will speed up to a 14.5% gain from 6.8% in 2023. They anticipate a further 12.5% EPS increase next year.

Analysts see sales rebounding 14% in full-year 2024 from a 0.1% decline last year, according to FactSet. Sales growth is seen accelerating to 16.4% next year.

On Wednesday, Wells Fargo raised its price target on BlackRock stock to $1,200 from $1,090, a 10% increase. The equity research firm kept an overweight rating on shares following BlackRock's HPS deal. Citing BlackRock's move into private assets, the firm said it sees earnings from such alternatives at 23% in 2026 vs. 13% in 2023, according to an analyst note seen by TheFly.com.

The firm expects earnings accretion from the HPS deal to be minimal in 2026. But the long-term opportunity is big and the shift to alternatives is multiple enhancing, Wells Fargo argued.

Since the Nov. 5 election, nine analysts out of 20 covering BlackRock stock have raised their price targets, FactSet shows. No one has cut.

The average price target of 1,107.06 suggests modest further upside for BLK stock, which sits on a 29% gain in 2024 so far.

Please follow Aparna Narayanan on X @IBD_Aparna for more coverage.

YOU MAY ALSO LIKE:

Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists

Looking For The Next Big Stock Market Winners? Start With These 3 Steps

Join IBD Live And Learn Top Chart Reading And Trading Techniques From Pros

Learn How To Time The Market With IBD's ETF Market Strategy